BMS-986397
Selleck Chemicals
SKU:E4725-5MG
Couldn't load pickup availability

BMS-986397 is a modulator of CK2 used in studies of Protein Degradation / Proteasome. It is especially relevant in cancer, cell signaling, and metabolism models, where defined compound exposure can be linked to ubiquitin-dependent turnover, proteostasis, and targeted protein degradation.
By modulating CK2, BMS-986397 can be used to examine ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving CK2
- Pathway perturbation studies connected to Protein Degradation / Proteasome
- Context-dependent response profiling and mechanism comparison
- Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
Overall, BMS-986397 is appropriate when a defined chemical perturbant is needed to connect CK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- CK2
- Target Class:
- Kinase
- Pathways:
- Protein Degradation / Proteasome
- Research Area:
- Cancer • Cell Signaling • Metabolism • Protein Homeostasis
- CAS No.:
- 2564486-44-6
- Molecular Weight:
- 480.83
- Formula:
- C₂₁H₁₆ClF₃N₄O₄
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.